| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | RADIUS HEALTH | 5,831,253 | 240,014,000 | 51.18% | ||
| 2 | PORTOLA PHARMACEUTICALS INC | 1,220,672 | 46,337,000 | 9.88% | ||
| 3 | EPIZYME INC COM | 2,163,819 | 40,637,000 | 8.67% | ||
| 4 | ARATANA THERAPEUTICS INC COM | 2,118,845 | 33,923,000 | 7.23% | ||
| 5 | NEVRO CORP | 686,704 | 32,914,000 | 7.02% | ||
| 6 | TRIVASCULAR TECHNOLOGIES INC | 1,776,692 | 18,637,000 | 3.97% | ||
| 7 | CELLADON CORP | 800,542 | 15,162,000 | 3.23% | ||
| 8 | Proteon Therapeutics | 983,381 | 11,437,000 | 2.44% | ||
| 9 | PHARMATHENE INC COM | 6,347,614 | 10,347,000 | 2.21% | ||
| 10 | CONATUS PHARMACEUTICALS INC COM | 1,192,080 | 8,488,000 | 1.81% | ||
| 11 | VERASTEM INC COM | 816,683 | 8,306,000 | 1.77% | ||
| 12 | MAST THERAPEUTICS | 2,551,851 | 1,250,000 | 0.27% | ||
| 13 | ENTEROMEDICS INC | 1,113,168 | 1,024,000 | 0.22% | ||
| 14 | SANGAMO BIOSCIENCES INCORPORATED | 22,487 | 353,000 | 0.08% | ||
| 15 | MACROGENICS INC | 3,168 | 99,000 | 0.02% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-004661, filed 2015.04.27).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
